TY - JOUR
T1 - Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club
AU - Wu, Eugene B.
AU - Brilakis, Emmanouil S.
AU - Lo, Sidney
AU - Kalyanasundaram, Arun
AU - Mashayekhi, Kambis
AU - Kao, Hsien Li
AU - Lim, Soo Teik
AU - Ge, Lei
AU - Chen, Ji Yan
AU - Qian, Jie
AU - Lee, Seung Whan
AU - Harding, Scott A.
AU - Tsuchikane, Etsuo
N1 - Funding Information:
Dr Wu is a proctor for Boston Scientific and Abbott Vascular. He has research grant from Asahi Intecc and Orbus Neich. Dr Brilakis has consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens. Shareholder: MHI Ventures. Board of Trustees: Society of Cardiovascular Angiography and Interventions. Dr Tsuchikane is consultant for Boston Scientific, NIPRO, and Asahi. Dr Kalyanasundaram is a consultant for Abbott Vascular and Boston Scientific. Dr Lo has received speaking and proctoring honoraria from Bio‐Excel. Dr Lim has received research grant/travel support or speaker honorarium from Orbus Neich, Asahi Intecc, Terumo, Biosensors, Biotronik, Abbott Vascular, Aluimedica, Boston Scientific, and Keneka. Dr Harding has received honoraria for speaking from Boston Scientific, Medtronic and Asahi and acted as a proctor for Boston Scientific and Bio‐excel.
Publisher Copyright:
© 2019 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.
PY - 2020/12
Y1 - 2020/12
N2 - Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate antegrade dissection and reentry, however its use is low outside North America and Europe. The Asia Pacific CTO Club along with three experience Stingray operators from the US, Europe and India, created an algorithm guiding use of the CrossBoss and Stingray catheter. This APCTO Stingray algorithm defines when to use the CrossBoss and Stingray device recommending a reduction in CrossBoss use except for in-stent restenosis lesions and immediate transition from knuckle wiring to the Stingray device. When antegrade wiring fails, choice of Stingray-facilitated reentry versus parallel wiring depends on operator experience, device availability, cost concerns, and anatomical factors. When the antegrade wire enters the subintimal space, we recommend using a rotational microcatheter to produce a channel and deliver the Stingray balloon—so called the “bougie technique.” We recommend early switch to Stingray rather than persisting with single wire redirection or parallel wire. We recommend choosing a suitable reentry zone based on preprocedural computer tomography or angiogram, routine use of stick and swap, routine use of Subintimal TRAnscatheter Withdrawal (STRAW) through the Stingray balloon, and the multi stick and swap technique. We believe these techniques and algorithm can facilitate incorporation of the Stingray balloon into the practice of CTO interventionists globally.
AB - Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in the various hybrid operators' CTO registries and is an important component of CTO crossing algorithms. The Stingray device can facilitate antegrade dissection and reentry, however its use is low outside North America and Europe. The Asia Pacific CTO Club along with three experience Stingray operators from the US, Europe and India, created an algorithm guiding use of the CrossBoss and Stingray catheter. This APCTO Stingray algorithm defines when to use the CrossBoss and Stingray device recommending a reduction in CrossBoss use except for in-stent restenosis lesions and immediate transition from knuckle wiring to the Stingray device. When antegrade wiring fails, choice of Stingray-facilitated reentry versus parallel wiring depends on operator experience, device availability, cost concerns, and anatomical factors. When the antegrade wire enters the subintimal space, we recommend using a rotational microcatheter to produce a channel and deliver the Stingray balloon—so called the “bougie technique.” We recommend early switch to Stingray rather than persisting with single wire redirection or parallel wire. We recommend choosing a suitable reentry zone based on preprocedural computer tomography or angiogram, routine use of stick and swap, routine use of Subintimal TRAnscatheter Withdrawal (STRAW) through the Stingray balloon, and the multi stick and swap technique. We believe these techniques and algorithm can facilitate incorporation of the Stingray balloon into the practice of CTO interventionists globally.
KW - CAD—coronary artery disease
KW - CTO—Chronic Total occlusion
KW - HRC—hybrid revascularization coronary
KW - PCI—percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85076215606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076215606&partnerID=8YFLogxK
U2 - 10.1002/ccd.28607
DO - 10.1002/ccd.28607
M3 - Article
C2 - 31769597
AN - SCOPUS:85076215606
SN - 1522-1946
VL - 96
SP - 1423
EP - 1433
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 7
ER -